GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Leveljump Healthcare Corp (OTCPK:JMPHF) » Definitions » COGS-to-Revenue

Leveljump Healthcare (Leveljump Healthcare) COGS-to-Revenue : 0.74 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Leveljump Healthcare COGS-to-Revenue?

Leveljump Healthcare's Cost of Goods Sold for the three months ended in Sep. 2023 was $1.57 Mil. Its Revenue for the three months ended in Sep. 2023 was $2.11 Mil.

Leveljump Healthcare's COGS to Revenue for the three months ended in Sep. 2023 was 0.74.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Leveljump Healthcare's Gross Margin % for the three months ended in Sep. 2023 was 25.86%.


Leveljump Healthcare COGS-to-Revenue Historical Data

The historical data trend for Leveljump Healthcare's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Leveljump Healthcare COGS-to-Revenue Chart

Leveljump Healthcare Annual Data
Trend Aug19 Aug20 Dec21 Dec22
COGS-to-Revenue
- - 0.80 0.73

Leveljump Healthcare Quarterly Data
Nov19 Aug20 Nov20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.72 0.73 0.73 0.74

Leveljump Healthcare COGS-to-Revenue Calculation

Leveljump Healthcare's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4.959 / 6.793
=0.73

Leveljump Healthcare's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1.565 / 2.111
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Leveljump Healthcare  (OTCPK:JMPHF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Leveljump Healthcare's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1.565 / 2.111
=25.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Leveljump Healthcare COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Leveljump Healthcare's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Leveljump Healthcare (Leveljump Healthcare) Business Description

Traded in Other Exchanges
Address
85 Scarsdale Road, Suite 304, Toronto, ON, CAN, M3B 2R2
Leveljump Healthcare Corp is engaged in the business of providing radiology solutions for hospitals, emergency rooms, and private clinics. The company offers telehealth services that are designed to provide a doctor-to-doctor collaboration and diagnosis allowing effective patient care.